Patients with mucous membrane pemphigoid should be monitored by a multidisciplinary team due to a risk for malignancy, according to a study.“Mucous membrane pemphigoid (MMP) comprises a group of ...

People with bullous pemphigoid are typically given topical or oral steroids to treat the “tense blisters” that show up on the arms, legs, lower body and occasionally in the mouth.

Bullous pemphigoid is a rare autoimmune disease that causes painful chronic blisters and welts. it typically strikes elderly people who already have one or more diseases or are in poor health.

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with systemic corticosteroids, Sanofi and Regeneron announced. The FDA’s ...

Pronounced “BULL-us PEM-fih-goyd” (with bullous being the medical term for a large blister), Bullous Pemphigoid is a rare, autoimmune, chronic skin disorder that causes large, fluid-fil… ...

Bullous pemphigoid can appear in the mucous membrane, causing lesions in the larynx, pharynx, tongue, nose and eyes. The disease is rare, with an estimated prevalence of one in 40,000, according ...

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in sustained disease remission and ...

Pemphigoid gestationis (PG) is a very rare pregnancy-associated autoimmune skin disease that is characterized by an itchy rash that progresses to form blisters. Initially, the rash appears around ...

Trial met the primary and all key secondary endpoints in adults with moderate-to-severe disease; five times more patients achieved sustained disease remission with Dupixent than placebo Dupixent ...